Strata Critical Medical Schedules Third Quarter 2026 Earnings Conference Call
Strata Critical Medical (SRTA) will release third-quarter 2026 financial results before the market opens on November 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Strata Critical Medical (SRTA) will release third-quarter 2026 financial results before the market opens on November 3, 2026. The quarter ended September 30, 2026. A conference call will follow at 8:00 a.m. Eastern Time, hosted by Co-Chief Executive Officers Melissa Tomkiel and Will Heyburn, with a participant question-and-answer session. A webcast replay will be available for one year.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the third quarter ended September 30, 2026 on Tuesday, November 3, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata’s Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants.
To join the live call, please register here. Upon registration, a dial-in and unique PIN will be provided to join the call.
An audio-only webcast of the call may be accessed from the Investors section of the Company’s website at https://ir.stratacritical.com/ or by registering at the link here. A replay of the webcast will be available for one year.
About Strata Critical Medical, Inc.
Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.
Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
For more information, visit www.srta.com.
Contacts
Mathew Schneider
investors@srta.com
